Cargando…
Pharmacology and toxicology of the novel investigational agent Cantrixil (TRX-E-002-1)
PURPOSE: Recurrent, chemo-resistant ovarian cancer is thought to be due to a subgroup of slow-growing, drug-resistant cancer cells with stem-like properties and a high capacity for tumour repair. Cantrixil targets this sub-population of cells and is being developed as an intraperitoneal therapy to b...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5306062/ https://www.ncbi.nlm.nih.gov/pubmed/28013349 http://dx.doi.org/10.1007/s00280-016-3224-2 |